Summary: The FDA approved the first brain-wave test for ADHD in children ages 6-17 which uses noninvasive procedures to measure theta-beta brain wave ratio. A higher theta-beta ratio indicates ADHD. The clinical trial involved 275 adolescents and children and has been shown to confirm an ADHD diagnosis.
- How will easy testing of ADHD affect the way children are treated in schools, homes, etc.?
– How will pharmaceutical companies react to the use of this test?
– How commonly will this test be used?
– Which demographic will most likely be using this test?
Original Article, For More Information: http://www.medscape.com/viewarticle/807869 (free account required for viewing)